Financial firms, including Jefferies, RBC, and Wells Fargo, issued rating and price objective updates for Biogen.
1 report, 1 independent
Updated Oct 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Financial firms, including Jefferies, RBC, and Wells Fargo, issued rating and price objective updates for Biogen.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Biogen
American multinational biotechnology company
-
Jefferies Financial Group
American financial services company
-
Royal Bank of Canada
financial institution in Canada
Related events
- Multiple financial firms, including Jefferies, Bank of America, and Raymond James, issued price objective and rating updates on October 23, 2026.
- MarketBeat reported average stock ratings while Jefferies Financial Group reiterated a buy rating for Sequoia Economic Infrastructure Inc.
- Royal Bank of Canada reaffirmed an outperform rating for Visa Inc., with average rating data provided by MarketBeat.
- Jefferies started coverage with a buy rating on Formula One Group, while MarketBeat provided the average stock rating.
- Royal Bank of Canada boosted its price objective for Seabridge Gold, with MarketBeat providing consensus rating data.